KREBS BIOCHEMICALS & INDUSTRIES
Back to Cashflow Statement
|
KREBS BIOCHEMICALS & INDUSTRIES Last 5 Year Cash Flow from Financing Activities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹5.56 Cr | ₹37 Cr | ₹40 Cr | ₹38 Cr | ₹29 Cr |
What is the latest Cash Flow from Financing Activities ratio of KREBS BIOCHEMICALS & INDUSTRIES ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹5.56 Cr |
Mar2023 | ₹37 Cr |
Mar2022 | ₹40 Cr |
Mar2021 | ₹38 Cr |
Mar2020 | ₹29 Cr |
How is Cash Flow from Financing Activities of KREBS BIOCHEMICALS & INDUSTRIES Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹5.56 Cr | -85.10 | |
Mar2023 | ₹37 Cr | -5.48 | |
Mar2022 | ₹40 Cr | 4.90 | |
Mar2021 | ₹38 Cr | 31.80 | |
Mar2020 | ₹29 Cr | - |
Compare Cash Flow from Financing Activities of peers of KREBS BIOCHEMICALS & INDUSTRIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
KREBS BIOCHEMICALS & INDUSTRIES | ₹183.6 Cr | 2.7% | -16.7% | 19.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹400,617.0 Cr | -2.1% | -9% | 9.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹158,655.0 Cr | 2.4% | 2.2% | 59.7% | Stock Analytics | |
CIPLA | ₹119,511.0 Cr | 1.4% | 2% | 0.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹104,734.0 Cr | -0.9% | -2.8% | 16.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,705.1 Cr | -2.1% | -9.2% | -8.7% | Stock Analytics |
KREBS BIOCHEMICALS & INDUSTRIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
KREBS BIOCHEMICALS & INDUSTRIES | 2.7% |
-16.7% |
19.7% |
SENSEX | -0.4% |
-1.4% |
5.4% |
You may also like the below Video Courses